Two New HPLC Methods, Assessed by GAPI, for Simultaneous Determination of Four Antipsychotics in Pharmaceutical Formulations: A Comparative Study

Two New HPLC Methods, Assessed by GAPI, for Simultaneous Determination of Four Antipsychotics in Pharmaceutical Formulations: A Comparative Study

Antipsychotics are widely used to treat various mental disorders. Combination therapies were approved by the FDA to treat manic states. Quetiapine fumarate, aripiprazole, asenapine maleate, and chlorpromazine HCl are frequently used for treatment of these disorders. Green analytical chemistry is pri...

Full description

Bibliographic Details
Main Authors:	Eman A. Abdel Hameed, Zaitona A. Abd El-Naby, Alaa El Gindy, Sawsan A. Zaitone, Reem Alshaman, Roshdy E. Saraya, Gasser M. Khairy
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Separations
Subjects:	quetiapine aripiprazole asenapine maleate chlorpromazine GAPI HPLC
Online Access:	https://www.mdpi.com/2297-8739/9/8/220

Similar Items

Two Eco-Friendly Chromatographic Methods Evaluated by GAPI for Simultaneous Determination of the Fluoroquinolones Moxifloxacin, Levofloxacin, and Gemifloxacin in Their Pharmaceutical Products
by: Eman A. Abdel Hameed, et al.
Published: (2022-10-01)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
by: Jolanta Orzelska-Górka, et al.
Published: (2022-09-01)

Antipsychotic-associated psoriatic rash – a case report
by: Camelia-Eugenia Bujor, et al.
Published: (2017-07-01)

Validation of an RP-HPLC Method for the Determination of Asenapine Maleate in Dissolution Media and Application to Study In Vitro Release from Co-Crystals
by: Suhair S. Al-Nimry, et al.
Published: (2021-03-01)

Boosting the In Vivo Transdermal Bioavailability of Asenapine Maleate Using Novel Lavender Oil-Based Lipid Nanocapsules for Management of Schizophrenia
by: Fatma Sa’eed El-Tokhy, et al.
Published: (2023-02-01)

Adjunctive quetiapine may help fluvoxamine-resistant obsessive-compulsive disorder among female in-patients: A randomized-controlled study
by: Saeed Shoja Shafti, et al.
Published: (2019-04-01)

Spectrofluorometric Determination of Baricitinib in Pure Form and Application on Pharmaceutical Dosage Form; Green Profile Evaluation via Eco-scale and GAPI Tools.
by: Ahmed Saleh, et al.
Published: (2022-12-01)

Green novel photometric and planar chromatographic assays of remdesivir: Comparative greenness assessment study using estimated GAPI tool versus ISO technical reported methods
by: Kamal Miranda F., et al.
Published: (2023-10-01)

Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews
by: Tamara Melnik, et al.

Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report
by: Anna Maria Szota, et al.
Published: (2020-04-01)

Is aripiprazole similar to quetiapine for treatment of bipolar depression? Results from meta-analysis of Chinese data
by: Hejian Tao, et al.
Published: (2022-09-01)

An eco-friendly HPLC method for concurrent determination of carbocisteine, guaifenesin, and oxomemazine in their combined formulations
by: Soad S. Abd El-Hay, et al.
Published: (2023-12-01)

Quetiapine Ameliorates MIA-Induced Impairment of Sensorimotor Gating: Focus on Neuron-Microglia Communication and the Inflammatory Response in the Frontal Cortex of Adult Offspring of Wistar Rats
by: Katarzyna Chamera, et al.
Published: (2022-09-01)

Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies
by: Mitali Patel, et al.
Published: (2019-12-01)

Electrochemical Studies for the Determination of Quetiapine Fumarate and Olanzapine Antipsychotic Drugs
by: Manal A. El-Shal
Published: (2013-08-01)

Atypical antipsychotics as add-on treatment in late-life depression
by: Cakir S, et al.
Published: (2016-09-01)

Transdermal Asenapine in Schizophrenia: A Systematic Review
by: Carrithers B, et al.
Published: (2020-08-01)

Chlorpromazine induced priapism from a single dose: an unusual complication of antipsychotic agent
by: Mohamed Ahmed Abd El Salam, et al.
Published: (2017-08-01)

Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication
by: Toshihiko Kinoshita, et al.
Published: (2023-09-01)

A comparative study of olanzapine versus asenapine in acute treatment of manic episode: A 3-week prospective study
by: Ajeet Sidana, et al.
Published: (2014-01-01)

Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial
by: Shuhei Wada, et al.
Published: (2023-03-01)

Quantitative Analysis of Dimetindene Maleate in Dosage Forms by Ion-pair Reversed- Phase HPLC
by: Kahtan Jassim Hasson
Published: (2014-12-01)

Cognitive Impairment in Schizophrenia, Neurotransmitters and the New Atypical Antipsychotic Aripiprazole
by: Topolov Mariyan K., et al.
Published: (2016-03-01)

Sustainable eco-friendly ratio-based spectrophotometric and HPTLC-densitometric methods for simultaneous analysis of co-formulated anti-migraine drugs with overlapped spectra
by: Christine Maged El-Maraghy
Published: (2023-08-01)

Quetiapine Addiction: A Case Report
by: A. Chaara, et al.
Published: (2022-06-01)

Development and validation of an eco-friendly HPLC–UV method for determination of atorvastatin and vitamin D3 in pure form and pharmaceutical formulation
by: Khaled Maged, et al.
Published: (2023-06-01)

Sexual disfunction in adolescents with antipsychotics. evaluation and suitability of the treatment
by: S. Pérez Sánchez, et al.
Published: (2021-04-01)

Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
by: Okazaki K, et al.
Published: (2017-11-01)

Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets
by: Caroline Brandão-Teles, et al.
Published: (2019-03-01)

Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis
by: Patrick Amoateng, et al.
Published: (2017-08-01)

Application of Three Ecological Assessment Tools in Examining Chromatographic Methods for the Green Analysis of a Mixture of Dopamine, Serotonin, Glutamate and GABA: A Comparative Study
by: Atiah H. Almalki, et al.
Published: (2021-09-01)

Corrigendum: Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets
by: Caroline Brandão-Teles, et al.
Published: (2019-04-01)

Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
by: Yi-Ting Lin, et al.
Published: (2015-02-01)

THE EFFECT OF LITHIUM ON ACUTE TOXICITY OF CHLORPROMAZINE IN MICE
by: Dehpour, et al.
Published: (1996-06-01)

THE EFFECT OF LITHIUM ON ACUTE TOXICITY OF CHLORPROMAZINE IN MICE
by: Dehpour, et al.
Published: (1996-06-01)

Effect of chlorpromazine on intact and irradiated aliquot ctdsDNA samples
by: Ali M. Abbed, et al.
Published: (2007-04-01)

Three new, UV spectrum filtration protocols for the synchronous quantification of ciprofloxacin HCl and ornidazole in the existence of ciprofloxacin-induced degradation compound
by: Amir Alhaj Sakur, et al.
Published: (2023-12-01)

Development and Greenness Evaluation of Spectrofluorometric Methods for Flibanserin Determination in Dosage Form and Human Urine Samples
by: Rasha Ahmed, et al.
Published: (2020-10-01)

KIPRAH POLITIK PAGUYUBAN PASUNDAN PERIODE 1927-1959
by: Andre Bagus Irshanto
Published: (2017-07-01)

Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
by: Nemanja N. Muric, et al.
Published: (2020-12-01)